2007
DOI: 10.1080/07420520601089547
|View full text |Cite
|
Sign up to set email alerts
|

Chronopharmacological Study of Cephalexin in Dogs

Abstract: Recent studies have identified a 24 h rhythm in the expression and function of PEPT1 in rats, with significantly higher levels during the nighttime than daytime. Similarly, temporal variations have been described in glomerular filtration rate and renal blood flow, both being maximal during the activity phase and minimal during the rest phase in laboratory rodents. The aim of this study was to assess the hypothesis that the absorption of the first-generation cephalosporin antibiotic cephalexin by dogs would be … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
13
0

Year Published

2007
2007
2020
2020

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 11 publications
(16 citation statements)
references
References 28 publications
3
13
0
Order By: Relevance
“…Boulamery et al 966 circadian-time dependent in rodents (Pons et al, 1996). These data agree with previously reported higher values of renal clearance for gentamicin, amikacin, tobramycin, and ampicillin in rodents (Lin et al, 1994;MesnardRici & White, 1998;Rao et al, 1997;Rebuelto et al, 2003aRebuelto et al, , 2003bWhite et al, 1995;Yoshiyama et al, 1993) and cephalexin in dogs (Prados et al, 2007) during the nocturnal activity span.…”
Section: Discussionsupporting
confidence: 93%
See 1 more Smart Citation
“…Boulamery et al 966 circadian-time dependent in rodents (Pons et al, 1996). These data agree with previously reported higher values of renal clearance for gentamicin, amikacin, tobramycin, and ampicillin in rodents (Lin et al, 1994;MesnardRici & White, 1998;Rao et al, 1997;Rebuelto et al, 2003aRebuelto et al, , 2003bWhite et al, 1995;Yoshiyama et al, 1993) and cephalexin in dogs (Prados et al, 2007) during the nocturnal activity span.…”
Section: Discussionsupporting
confidence: 93%
“…Some studies have reported circadian rhythm dependencies in the pharmacokinetics of certain antimicrobial agents (gentamicin, tobramicin, ampicillin, isepamicin, amphotericin B, cephalexin, cephtriaxone, and norfloxacin) in the rat, dogs, or man (Lin et al, 1994;Mesnard-Rici & White, 1998;Prados et al, 2007;Rao et al, 1997;Rebuelto et al, 2003aRebuelto et al, , 2003bWhite et al, 1995;Yoshiyama et al, 1993), but the present work is the first one demonstrating chronopharmacokinetic changes in a betalactam antibiotic agent (i.e., imipenem).…”
Section: Discussionmentioning
confidence: 88%
“…C max was higher after the daytime administration and decreased significantly by 19% in night-time administration, and is in good agreement with the reported cephalexin chronokinetics in dogs (Prados et al 2007). Similarly, the rats administered oral ceftibuten, another b-lactam antibiotic substrate of PEPT1, at 20:00 h showed greater C max than rats administered this medication at 08:00 h (Pan et al 2003).…”
Section: Discussionsupporting
confidence: 83%
“…43, No. 5, October 2012 identified that b-lactam antibiotics (cephalexin) pharmacokinetics varies with time of administration in fasted dogs (Prados et al 2007). Nevertheless, there seems to be little understanding about the chronokinetics of b-lactam antibiotics in human.…”
Section: Please Scroll Down For Articlementioning
confidence: 99%
“…Chronomedicine is the study of the chronobiology of health and disease and the translation of applicable findings to clinical medicine (Portaluppi, 2007). In the past few years, in particular, a chronobiological approach has been extensively used in medical research, leading to a better understanding of the pathophysiological mechanisms and features of many medical conditions and public health problems (Burioka et al, 2008;Colognesi et al, 2007;Kawahara et al, 2008;Lee et al, 2008;Leibowitz et al, 2007;Leiza et al, 2007;Lin et al, 2008;Mbanu et al, 2007;Ohkura et al, 2007;Perez-Lloret et al, 2008;Sadick et al, 2007;Sallinen et al, 2008;Shah et al, 2007;Tsai et al, 2007) as well as greater insight of therapeutic issues (Boulamery et al, 2007;Bruguerolle, 2008;Coudert et al, 2008;Dispersyn et al, 2008;Dridi et al, 2008;Hermida, 2007;Hermida et al, 2007bHermida et al, , 2008Prados et al, 2007;Smolensky et al, 2007;Tsuruoka et al, 2008).…”
Section: Introductionmentioning
confidence: 99%